{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:47:29Z","timestamp":1792615649627,"version":"4.5.0"},"reference-count":133,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/ogx.0b013e31822dfbe2","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T14:10:47Z","timestamp":1317737447000},"page":"431-442","source":"Crossref","is-referenced-by-count":22,"title":["Cell-Free Fetal Nucleic Acid Testing: A Review of the Technology and Its Applications"],"prefix":"10.1097","volume":"66","author":[{"given":"Lauren C.","family":"Sayres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildred K.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210212","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(69)91642-0","article-title":"Practical and theoretical implications of fetal-maternal lymphocyte transfer.","volume":"1","author":"Walknowska","year":"1969","journal-title":"Lancet"},{"key":"R2-21-20210212","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pd.1970141308","article-title":"Isolating fetal cells in maternal circulation for prenatal diagnosis.","volume":"14","author":"Simpson","year":"1994","journal-title":"Prenat Diagn"},{"key":"R3-21-20210212","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0022-3476(95)70018-8","article-title":"Prenatal diagnosis by analysis of fetal cells in maternal blood.","volume":"127","author":"Bianchi","year":"1995","journal-title":"J Pediatr"},{"key":"R4-21-20210212","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00003081-199612000-00009","article-title":"Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review.","volume":"39","author":"Steele","year":"1996","journal-title":"Clin Obstet Gynecol"},{"key":"R5-21-20210212","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/8.6.493","article-title":"Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis.","volume":"8","author":"Bischoff","year":"2002","journal-title":"Hum Reprod Update"},{"key":"R6-21-20210212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum.","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"R7-21-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pd.1700","article-title":"Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.","volume":"27","author":"Alberry","year":"2007","journal-title":"Prenat Diagn"},{"key":"R8-21-20210212","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00439-003-0987-4","article-title":"Evaluation of bidirectional transfer of plasma DNA through placenta.","volume":"113","author":"Sekizawa","year":"2003","journal-title":"Hum Genet"},{"key":"R9-21-20210212","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajog.2004.12.015","article-title":"Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA.","volume":"193","author":"Wataganara","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R10-21-20210212","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/clinchem\/46.11.1832","article-title":"Presence of fetal RNA in maternal plasma.","volume":"46","author":"Poon","year":"2000","journal-title":"Clin Chem"},{"key":"R11-21-20210212","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1373\/clinchem.2004.042713","article-title":"Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation.","volume":"51","author":"Birch","year":"2005","journal-title":"Clin Chem"},{"key":"R12-21-20210212","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/clinchem\/46.9.1301","article-title":"Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA.","volume":"46","author":"Lo","year":"2000","journal-title":"Clin Chem"},{"key":"R13-21-20210212","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma.","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R14-21-20210212","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.","volume":"62","author":"Lo","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R15-21-20210212","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1472-6483(10)60645-1","article-title":"Recovery and amplification of placental RNA from dried maternal blood spots: utility for non-invasive prenatal diagnosis.","volume":"13","author":"Jorgez","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R16-21-20210212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1472-6483(10)61856-1","article-title":"Detecting fetal DNA from dried maternal blood spots: another step towards broad scale non-invasive prenatal genetic screening and feasible testing.","volume":"6","author":"Bischoff","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"R17-21-20210212","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/clinchem\/48.1.35","article-title":"Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma.","volume":"48","author":"Poon","year":"2002","journal-title":"Clin Chem"},{"key":"R18-21-20210212","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nm1530","article-title":"Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection.","volume":"13","author":"Lo","year":"2007","journal-title":"Nat Med"},{"key":"R19-21-20210212","doi-asserted-by":"crossref","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","article-title":"Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.","volume":"2","author":"Lo","year":"2010","journal-title":"Sci Transl Med"},{"key":"R21-21-20210212","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(94)91769-8","article-title":"Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10\u201313 weeks' gestation.","volume":"344","author":"Nicolaides","year":"1994","journal-title":"Lancet"},{"key":"R22-21-20210212","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/uog.2674","article-title":"Fetal gender assignment by first-trimester ultrasound.","volume":"27","author":"Efrat","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R23-21-20210212","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00006250-200702000-00063","article-title":"ACOG Committee Opinion No. 360: Sex selection.","volume":"109","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R24-21-20210212","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/pd.1284","article-title":"Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy.","volume":"25","author":"Hyett","year":"2005","journal-title":"Prenat Diagn"},{"key":"R25-21-20210212","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pd.586","article-title":"A new approach to antenatal screening for Fragile X syndrome.","volume":"23","author":"Wald","year":"2003","journal-title":"Prenat Diagn"},{"key":"R26-21-20210212","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","article-title":"Fragile X syndrome: diagnostic and carrier testing.","volume":"7","author":"Sherman","year":"2005","journal-title":"Genet Med"},{"key":"R27-21-20210212","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJM200205093461918","article-title":"New strategy for prenatal diagnosis of X-linked disorders.","volume":"346","author":"Costa","year":"2002","journal-title":"N Engl J Med"},{"key":"R28-21-20210212","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2516.2006.01298.x","article-title":"Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia.","volume":"12","author":"Santacroce","year":"2006","journal-title":"Haemophilia"},{"key":"R29-21-20210212","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-21-20210212","first-page":"374","article-title":"Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia.","volume":"98","author":"Rijnders","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R31-21-20210212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00439-001-0649-3","article-title":"Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum.","volume":"110","author":"Honda","year":"2002","journal-title":"Hum Genet"},{"key":"R32-21-20210212","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/pd.219","article-title":"First-trimester fetal sex determination in maternal serum using real-time PCR.","volume":"21","author":"Costa","year":"2001","journal-title":"Prenat Diagn"},{"key":"R33-21-20210212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pd.556","article-title":"Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination.","volume":"23","author":"Hromadnikova","year":"2003","journal-title":"Prenat Diagn"},{"key":"R34-21-20210212","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/clinchem\/47.10.1856","article-title":"Accuracy of fetal gender determination by analysis of DNA in maternal plasma.","volume":"47","author":"Sekizawa","year":"2001","journal-title":"Clin Chem"},{"key":"R40-21-20210212","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.AOG.0000199427.83503.d0","article-title":"At-home fetal DNA gender testing: caveat emptor.","volume":"107","author":"Bianchi","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R42-21-20210212","article-title":"Cell-free fetal nucleic acids for noninvasive prenatal diagnosis: report of the UK expert working group.","author":"Wright","year":"2009"},{"key":"R43-21-20210212","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-59745-553-4_11","article-title":"The use of maternal plasma for prenatal RhD blood group genotyping.","volume":"496","author":"Finning","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R44-21-20210212","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erm.10.5","article-title":"Noninvasive fetal RhD genotyping from maternal blood.","volume":"10","author":"Kolialexi","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"R45-21-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00006250-200608000-00044","article-title":"ACOG Practice Bulletin No. 75: management of alloimmunization.","volume":"108","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R46-21-20210212","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/AOG.0b013e31817d453c","article-title":"Management of rhesus alloimmunization in pregnancy.","volume":"112","author":"Moise","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R47-21-20210212","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis.","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"R48-21-20210212","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bmj.39556.499549.80","article-title":"Fetal RHD typing: is fetal RHD typing in all RhD negative women cost effective?","volume":"336","author":"Szczepura","year":"2008","journal-title":"BMJ"},{"issue":"S1","key":"R49-21-20210212","first-page":"A139","article-title":"Should free fetal DNA testing replace antenatal anti-D administration for prevention of Rhesus alloimmunization?","volume":"204","author":"Ma","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R50-21-20210212","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(05)60534-X","article-title":"Detection of fetal RHD-specific sequences in maternal plasma.","volume":"352","author":"Faas","year":"1998","journal-title":"Lancet"},{"key":"R51-21-20210212","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/107155769900600203","article-title":"Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR.","volume":"6","author":"Bischoff","year":"1999","journal-title":"J Soc Gynecol Investig"},{"key":"R52-21-20210212","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajog.2006.07.033","article-title":"Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood\u2014a meta-analysis.","volume":"195","author":"Geifman-Holtzman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R53-21-20210212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tracli.2006.02.021","article-title":"Non-invasive antenatal RHD typing.","volume":"13","author":"Van der Schoot","year":"2006","journal-title":"Transfus Clin Biol"},{"key":"R55-21-20210212","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.","volume":"336","author":"Finning","year":"2008","journal-title":"BMJ"},{"key":"R56-21-20210212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-59745-066-9_20","article-title":"Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.","volume":"444","author":"Ding","year":"2008","journal-title":"Methods Mol Biol"},{"key":"R57-21-20210212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pd.1936","article-title":"Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.","volume":"28","author":"Li","year":"2008","journal-title":"Prenat Diagn"},{"key":"R58-21-20210212","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/dmn047","article-title":"The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.","volume":"15","author":"Wright","year":"2009","journal-title":"Hum Reprod Update"},{"key":"R60-21-20210212","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.2000.tb06605.x","article-title":"Multiplex and real-time quantitative PCR on fetal DNA in maternal plasma. A comparison with fetal cells isolated from maternal blood.","volume":"906","author":"Hahn","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R61-21-20210212","first-page":"70","article-title":"Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma.","volume":"131","author":"Zhong","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"R62-21-20210212","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion"},{"key":"R63-21-20210212","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/AOG.0b013e31817d252f","article-title":"ACOG Committee Opinion No. 410: ethical issues in genetic testing.","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R64-21-20210212","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00005650-199408000-00008","article-title":"A cost-effectiveness analysis of amniocentesis and chorionic villus sampling for prenatal genetic testing.","volume":"32","author":"Heckerling","year":"1994","journal-title":"Med Care"},{"key":"R65-21-20210212","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/clinchem\/46.2.301","article-title":"Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma.","volume":"46","author":"Amicucci","year":"2000","journal-title":"Clin Chem"},{"key":"R66-21-20210212","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/pd.1030","article-title":"Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma\u2014case report.","volume":"24","author":"Li","year":"2004","journal-title":"Prenat Diagn"},{"key":"R67-21-20210212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pd.607","article-title":"Prenatal detection of fetal hemoglobin E gene from maternal plasma.","volume":"23","author":"Fucharoen","year":"2003","journal-title":"Prenat Diagn"},{"key":"R68-21-20210212","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(00)02767-7","article-title":"Prenatal DNA diagnosis of a single-gene disorder from maternal plasma.","volume":"356","author":"Saito","year":"2000","journal-title":"Lancet"},{"key":"R69-21-20210212","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/pd.570","article-title":"Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR.","volume":"23","author":"Gonzalez-Gonzalez","year":"2003","journal-title":"Prenat Diagn"},{"key":"R70-21-20210212","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/01.WNL.0000056084.13096.8A","article-title":"Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR.","volume":"60","author":"Gonzalez-Gonzalez","year":"2003","journal-title":"Neurology"},{"key":"R71-21-20210212","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1468-1331.2008.02312.x","article-title":"Prenatal diagnosis of Huntington disease in maternal plasma: direct and indirect study.","volume":"15","author":"Bustamante-Aragones","year":"2008","journal-title":"Eur J Neurol"},{"key":"R72-21-20210212","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1159\/000095662","article-title":"Non-invasive prenatal detection of paternal origin hb lepore in a male fetus at the 7th week of gestation.","volume":"21","author":"Lazaros","year":"2006","journal-title":"Fetal Diagn Ther"},{"key":"R73-21-20210212","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bmt.1703411","article-title":"Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma.","volume":"29","author":"Reed","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R74-21-20210212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00414-008-0292-9","article-title":"Non-invasive prenatal paternity testing from maternal blood.","volume":"123","author":"Wagner","year":"2009","journal-title":"Int J Legal Med"},{"key":"R75-21-20210212","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/pd.439","article-title":"Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma.","volume":"22","author":"Gonzalez-Gonzalez","year":"2002","journal-title":"Prenat Diagn"},{"key":"R76-21-20210212","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinchem\/48.5.778","article-title":"Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study.","volume":"48","author":"Chiu","year":"2002","journal-title":"Clin Chem"},{"key":"R77-21-20210212","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1373\/clinchem.2003.025981","article-title":"Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis.","volume":"50","author":"Nasis","year":"2004","journal-title":"Clin Chem"},{"key":"R78-21-20210212","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(02)11086-5","article-title":"Prenatal exclusion of beta thalassaemia major by examination of maternal plasma.","volume":"360","author":"Chiu","year":"2002","journal-title":"Lancet"},{"key":"R79-21-20210212","doi-asserted-by":"crossref","first-page":"19920","DOI":"10.1073\/pnas.0810373105","article-title":"Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma.","volume":"105","author":"Lun","year":"2008","journal-title":"P Natl Acad Sci USA"},{"key":"R80-21-20210212","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2010-10-310789","article-title":"Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA.","volume":"117","author":"Tsui","year":"2011","journal-title":"Blood"},{"key":"R81-21-20210212","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.0403962101","article-title":"MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis.","volume":"101","author":"Ding","year":"2004","journal-title":"P Natl Acad Sci USA"},{"key":"R82-21-20210212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000223442","article-title":"Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry.","volume":"25","author":"Li","year":"2009","journal-title":"Fetal Diagn Ther"},{"key":"R83-21-20210212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pd.1608","article-title":"Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay.","volume":"27","author":"Li","year":"2007","journal-title":"Prenat Diagn"},{"key":"R84-21-20210212","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1373\/clinchem.2003.029835","article-title":"Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms.","volume":"50","author":"Li","year":"2004","journal-title":"Clin Chem"},{"key":"R85-21-20210212","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.293.7.843","article-title":"Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma.","volume":"293","author":"Li","year":"2005","journal-title":"JAMA"},{"key":"R86-21-20210212","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma.","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"key":"R87-21-20210212","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000235877","article-title":"Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification.","volume":"25","author":"Jorgez","year":"2009","journal-title":"Fetal Diagn Ther"},{"key":"R88-21-20210212","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1373\/clinchem.2009.127480","article-title":"Microsystem for isolation of fetal DNA from maternal plasma by preparative size separation.","volume":"55","author":"Hahn","year":"2009","journal-title":"Clin Chem"},{"key":"R89-21-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1368.018","article-title":"Different approaches for noninvasive prenatal diagnosis of genetic diseases based on PNA-mediated enriched PCR.","volume":"1075","author":"Galbiati","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R90-21-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1098-2280(1996)28:3<167::AID-EM2>3.0.CO;2-B","article-title":"Human aneuploidy: incidence, origin, and etiology.","volume":"28","author":"Hassold","year":"1996","journal-title":"Environ Mol Mutagen"},{"key":"R91-21-20210212","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome.","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"R92-21-20210212","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1471-0528.2003.02246.x","article-title":"Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.","volume":"110","author":"Spencer","year":"2003","journal-title":"BJOG"},{"key":"R93-21-20210212","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/01.AOG.0000291570.63450.44","article-title":"ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R94-21-20210212","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.AOG.0000174581.24338.6f","article-title":"A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.","volume":"106","author":"Odibo","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R95-21-20210212","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1586\/erm.09.43","article-title":"Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies.","volume":"9","author":"Hahn","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"R96-21-20210212","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nm0311-250","article-title":"Community corner: opening the Pandora's box of prenatal genetic testing.","volume":"17","author":"Wright","year":"2011","journal-title":"Nat Med"},{"key":"R97-21-20210212","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.1073\/pnas.0503335102","article-title":"Detection of the placental epigenetic signature of the maspin gene in maternal plasma.","volume":"102","author":"Chim","year":"2005","journal-title":"P Natl Acad Sci USA"},{"key":"R98-21-20210212","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1373\/clinchem.2006.076851","article-title":"Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations.","volume":"52","author":"Tong","year":"2006","journal-title":"Clin Chem"},{"key":"R99-21-20210212","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1373\/clinchem.2006.074997","article-title":"Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.","volume":"52","author":"Chan","year":"2006","journal-title":"Clin Chem"},{"key":"R100-21-20210212","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1472-6483(10)60713-4","article-title":"Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.","volume":"15","author":"Old","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R101-21-20210212","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1373\/clinchem.2010.146290","article-title":"Quantification of fetal DNA by use of methylation-based DNA discrimination.","volume":"56","author":"Nygren","year":"2010","journal-title":"Clin Chem"},{"key":"R102-21-20210212","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1373\/49.9.1445","article-title":"Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma.","volume":"49","author":"Oudejans","year":"2003","journal-title":"Clin Chem"},{"key":"R103-21-20210212","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/CCLM.2011.099","article-title":"Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification.","volume":"49","author":"Deng","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"R104-21-20210212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jmg.2003.016881","article-title":"Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling.","volume":"41","author":"Tsui","year":"2004","journal-title":"J Med Genet"},{"key":"R105-21-20210212","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/clinchem\/48.2.362","article-title":"Novel real-time quantitative PCR test for trisomy 21.","volume":"48","author":"Zimmermann","year":"2002","journal-title":"Clin Chem"},{"key":"R106-21-20210212","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1073\/pnas.0705765104","article-title":"Digital PCR for the molecular detection of fetal chromosomal aneuploidy.","volume":"104","author":"Lo","year":"2007","journal-title":"P Natl Acad Sci USA"},{"key":"R107-21-20210212","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1021\/ac0709394","article-title":"Detection of aneuploidy with digital polymerase chain reaction.","volume":"79","author":"Fan","year":"2007","journal-title":"Anal Chem"},{"key":"R108-21-20210212","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.","volume":"105","author":"Chiu","year":"2008","journal-title":"P Natl Acad Sci USA"},{"key":"R109-21-20210212","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.","volume":"105","author":"Fan","year":"2008","journal-title":"P Natl Acad Sci USA"},{"key":"R110-21-20210212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1373\/clinchem.2010.154336","article-title":"Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles.","volume":"57","author":"Liao","year":"2011","journal-title":"Clin Chem"},{"key":"R111-21-20210212","doi-asserted-by":"crossref","first-page":"e10439","DOI":"10.1371\/journal.pone.0010439","article-title":"Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics.","volume":"5","author":"Fan","year":"2010","journal-title":"PLoS One"},{"key":"R112-21-20210212","first-page":"57","article-title":"Noninvasive prenatal diagnosis of a case of Down syndrome due to Robertsonian translocation by massively parallel sequencing of maternal plasma DNA.","author":"Lun","year":"2011","journal-title":"Clin Chem"},{"key":"R113-21-20210212","doi-asserted-by":"crossref","first-page":"c7401","DOI":"10.1136\/bmj.c7401","article-title":"Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.","volume":"342","author":"Chiu","year":"2011","journal-title":"BMJ"},{"key":"R114-21-20210212","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/j.ajog.2010.12.060","article-title":"Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.","volume":"204","author":"Ehrich","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R115-21-20210212","first-page":"57","article-title":"Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood.","author":"Sehnert","year":"2011","journal-title":"Clin Chem"},{"key":"R116-21-20210212","doi-asserted-by":"crossref","first-page":"e13184","DOI":"10.1371\/journal.pone.0013184","article-title":"Non-invasive prenatal detection of trisomy 21 using tandem single nucleotide polymorphisms.","volume":"5","author":"Ghanta","year":"2010","journal-title":"PLoS One"},{"key":"R117-21-20210212","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.siny.2007.12.008","article-title":"Non-invasive prenatal diagnosis of single gene disorders: how close are we?","volume":"13","author":"Norbury","year":"2008","journal-title":"Seminin Fetal Neonatal Med"},{"key":"R118-21-20210212","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1373\/clinchem.2003.023259","article-title":"Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients.","volume":"50","author":"Sekizawa","year":"2004","journal-title":"Clin Chem"},{"key":"R119-21-20210212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/clinchem\/45.2.184","article-title":"Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia.","volume":"45","author":"Lo","year":"1999","journal-title":"Clin Chem"},{"key":"R120-21-20210212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/PRG-120002911","article-title":"The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.","volume":"21","author":"Zhong","year":"2002","journal-title":"Hypertens Pregnancy"},{"key":"R121-21-20210212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pd.788","article-title":"Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.","volume":"24","author":"Farina","year":"2004","journal-title":"Prenat Diagn"},{"key":"R122-21-20210212","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/clinchem\/48.2.353","article-title":"Increased cell-free fetal DNA in plasma of two women with invasive placenta.","volume":"48","author":"Sekizawa","year":"2002","journal-title":"Clin Chem"},{"key":"R123-21-20210212","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/clinchem\/47.12.2164","article-title":"Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum.","volume":"47","author":"Sekizawa","year":"2001","journal-title":"Clin Chem"},{"key":"R124-21-20210212","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0140-6736(05)60395-9","article-title":"Maternal plasma fetal DNA as a marker for preterm labour.","volume":"352","author":"Leung","year":"1998","journal-title":"Lancet"},{"key":"R125-21-20210212","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mob.2001.109594","article-title":"Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.","volume":"184","author":"Zhong","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R126-21-20210212","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1067\/mob.2003.27","article-title":"Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction.","volume":"188","author":"Sekizawa","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R127-21-20210212","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1172\/JCI29959","article-title":"Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood.","volume":"117","author":"Maron","year":"2007","journal-title":"J Clin Invest"},{"key":"R128-21-20210212","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pd.1780","article-title":"Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia.","volume":"27","author":"Purwosunu","year":"2007","journal-title":"Prenat Diagn"},{"key":"R129-21-20210212","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/pd.1562","article-title":"Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.","volume":"26","author":"Farina","year":"2006","journal-title":"Prenat Diagn"},{"key":"R130-21-20210212","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1373\/49.5.727","article-title":"The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia.","volume":"49","author":"Ng","year":"2003","journal-title":"Clin Chem"},{"key":"R131-21-20210212","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0378-3782(96)01811-7","article-title":"Ethical aspects of non-invasive prenatal diagnosis: medical, market, or regulatory model?","volume":"47","author":"Annas","year":"1996","journal-title":"Early Hum Dev"},{"key":"R132-21-20210212","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/jama.2009.707","article-title":"Practical and ethical considerations of noninvasive prenatal diagnosis.","volume":"301","author":"Benn","year":"2009","journal-title":"JAMA"},{"key":"R133-21-20210212","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/GCO.0b013e3283372352","article-title":"Ethical challenges in providing noninvasive prenatal diagnosis.","volume":"22","author":"Benn","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R134-21-20210212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10728-010-0146-8","article-title":"Should non-invasiveness change informed consent procedures for prenatal diagnosis?","volume":"19","author":"Deans","year":"2010","journal-title":"Health Care Anal"},{"key":"R135-21-20210212","first-page":"1","article-title":"The coming revolution in prenatal genetic testing.","volume":"23","author":"Greely","year":"2010","journal-title":"Prof Ethics Rep"},{"key":"R137-21-20210212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000279626","article-title":"Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications.","volume":"13","author":"Hall","year":"2010","journal-title":"Public Health Genomics"},{"key":"R138-21-20210212","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.siny.2007.12.009","article-title":"Non-invasive prenatal diagnosis: public and patient perceptions.","volume":"13","author":"Kent","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"R139-21-20210212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.siny.2007.12.004","article-title":"Ethical aspects arising from non-invasive fetal diagnosis.","volume":"13","author":"Newson","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"R141-21-20210212","doi-asserted-by":"crossref","first-page":"b2690","DOI":"10.1136\/bmj.b2690","article-title":"Commentary: no risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing.","volume":"339","author":"Schmitz","year":"2009","journal-title":"BMJ"},{"key":"R142-21-20210212","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrg2631","article-title":"An offer you can't refuse? Ethical implications of non-invasive prenatal diagnosis.","volume":"10","author":"Schmitz","year":"2009","journal-title":"Nat Rev Genet"},{"key":"R143-21-20210212","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/pd.1476","article-title":"The obstetrician's view: ethical and societal implications of non-invasive prenatal diagnosis.","volume":"26","author":"Smith","year":"2006","journal-title":"Prenat Diagn"},{"key":"R144-21-20210212","doi-asserted-by":"crossref","first-page":"b2451","DOI":"10.1136\/bmj.b2451","article-title":"Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing.","volume":"339","author":"Wright","year":"2009","journal-title":"BMJ"}],"container-title":["Obstetrical &amp; Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006254-201107000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:06Z","timestamp":1786047786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006254-201107000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":133,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e31822dfbe2","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}